Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Arbaclofen by Allos Pharma for Unspecified Genetic Disorders: Likelihood of Approval
Arbaclofen is under clinical development by Allos Pharma and currently in Phase II for Unspecified Genetic Disorders. According to GlobalData,...